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4 Nitric oxide (NO) is involved in many physiological functions such as neurotransmission, intercellular signal transduction, vasodilatation, and anticancer-antimicrobial activities (Nathan, 1992; Michel and Feron, 1997) . NO is produced by three distinct types of NO synthases (NOS): endothelial constitutive NOS, inducible NOS (iNOS), and neuronal constitutive NOS (Michel and Feron, 1997; Stuehr, 1999) . NO generation by these enzymes is tightly regulated either through intracellular free calcium concentration for constitutive forms of NOS (cNOS), or mainly through transcriptional induction for iNOS Fleming and Busse, 2003) .
However, overproduction of NO is highly toxic (Hobbs et al., 1999) . Furthermore, excess and prolonged activation of iNOS is associated with inflammatory tissue damage in various disease states, such as septicemia, rheumatoid arthritis, neurodegenerative diseases, and diabetes mellitus (Albina and Reichner, 1998) . Thus, inhibition of excessive NO generation, particularly from iNOS, has been considered as one method to ameliorate inflammatory tissue injury (Nathan, 1992; Hobbs et al., 1999) .
There are several ways to suppress iNOS activity. One is direct inhibition of the enzyme activity mainly by analogues of L-arginine, a substrate of the enzyme (Babu and Griffith, 1998) . However, this made of inhibition may affect both types of NOS, cNOS and iNOS. Treatment with L-arginine analogues exhibited side effects like hypertension in experimental animals (Molnar et al., 1994) . Thus, many researches have now focused on developing NOS type-specific inhibitors (Babu and Griffith, 1998; Tsymbalov et al., 2002) . Another way to suppress NO generation from iNOS is to inhibit the expression of the enzyme. Expression of iNOS is regulated primarily at the stage of transcriptional initiation to produce mRNA from the gene . The JPET #63693 5 promoter region of the iNOS gene has various transcription factor binding sites, such as interferon-γ-response element, activator protein-1 site, tumor necrosis factor-responsive element, and nuclear factor-κB (NF-κB) binding site (Xie et al., 1993; Lowenstein et al., 1993) . Among them, binding of NF-κB to the promoter is considered as a critical step for the expression of iNOS Kim et al., 1995) .
Several substances isolated from natural products suppress iNOS expression, and have been suggested to be possible anti-inflammatory agents (Yeo et al., 1998; Lee et al., 1998; Seo et al., 2000; Lo et al., 2002; Han et al., 2002; Wang et al., 2002) . In several areas of the world, plants in Cucurbitaceae family have been used as a traditional medicinal herb to suppress various symptoms, such as fever, cough, flu, and headache (Sohn et al., 2000) . Several compounds with the core structure of a tetracyclic triterpene were isolated from roots of the plant, and named cucurbitacin B, C, E and I. These have shown anti-cancer and anti-inflammatory activities (Konoshima et al., 1995; Duncan et al., 1996; Peters et al., 1999) . However, these cucurbitacins have not been developed as therapeutic agents, because of their strong cytotoxicities.
Several years ago a new cucurbitacin, 23, 24-dihycrocucurbitacin D (DHCD, Fig. 1 ), was isolated from roots of Bryonia alba L. (Cucurbitaceae) collected in Armenia. Unlike other cucurbitacins, DHCD was not toxic to non-tumor cells, while toxic to tumor cells Sohn et al., 2000) . Therefore, it would be valuable to test the effect of DHCD on iNOS induction, and to examine the possibilities for future development of its derivatives or analogs as anti-inflammatory agents. In the present study we investigated the inhibitory effect of DHCD on the generation of NO and the activation of NF-κB in mouse peritoneal macrophages.
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Materials and Methods
Materials. DHCD was purified and isolated from roots of B. alba L. from Armenia as described . Roots of B. alba L. were air-dried, powdered, extracted with 80% methanol, and evaporated at <40 o C.
Ethylacetate-soluble fraction was obtained from the methanol extract, and subjected to a silica gel column chromatography to isolate DHCD. The purity (>99%) and structure were determined by thin layer chromatography, and infrared and nuclear magnetic resonance spectroscopies, respectively Sohn et al., 2000) . Stock solution of DHCD (800 mM) was dissolved in dimethylsulfoxide, kept at -70 o C, and diluted with cell culture medium before use. Interferon-γ (IFNγ) was from Genzyme (Cambridge, MA). Fetal bovine serum was from GIBCO/BRL (Rockville, MD). Acrylamide, bis-acrylamide, ammonium sulfate were from Bio-Rad (Hercules, CA). Antibodies against mouse macrophage iNOS were obtained from Upstate Biotechnology (Lake Placid, NY). All other chemicals were purchased from Sigma (St. Louis, MO) unless otherwise noted.
Cell Culture and Measurement of NO Production. Thioglycollate-elicited peritoneal macrophages were obtained from ICR mice (Daehan Experimental Animals, Eumsung, Korea) as described .
Experiments using mice were carried out in accordance with the Guide for the Care and Use of Laboratory Animals, National Academy of Science. Macrophages were cultured in DMEM containing 10% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine at 37 o C in humidified 5% CO 2 /95% JPET #63693 7 air. For the induction of iNOS, cells were dispensed on 96-well plates (1×10 6 cells/ml, 0.1 ml/well), and activated with IFNγ (12.5 U/ml) and lipopolysaccharide (LPS, 12.5 ng/ml). After 12 h Griess assay was performed to measure concentrations of accumulated nitrite or nitrate plus nitrite as stable oxidation products of NO in the medium (Kwon et al., 1994; Kim et al., 1995) . Cell viability was determined by tetrazolium reduction by using MTT assay .
Western Analysis and Electrophoretic Mobility Shift Assay (EMSA).
Lysates of activated peritoneal macrophages were obtained by a brief sonication after suspension in 60 mM Tris containing 1% SDS and protease inhibitors. Protein concentration was measured by BCA reagent (Pierce, Rockford, IL). Lysates with 40 µg protein were subjected to 10% SDS-PAGE gels and transferred to nitrocellulose membrane (Trans-Blot; BioRad) at 4 o C in a tris-glycine buffer (39 mM tris, 48 mM glycine, 0.037% SDS, 20% methanol, pH 7.4).
Membranes were then blocked with 5% skim milk in TTBS (25 mM tris, pH 7.5, 150 mM NaCl, 0.1% Tween-20), washed 3 times with TTBS, and incubated with anti-iNOS antibody (1:1000) for 1 h. The membrane was then washed with TTBS, and subjected to a procedure for Enhanced Chemiluminescence (Pierce, Rockford, IL).
Nuclear extracts from activated macrophages were prepared and subjected to EMSA for detecting NF-κB activation as described using NF-κB Consensus Oligonucleotide and Gel Shit Assay Core System (Promega, Madison, WI).
Northern Analysis and Reverse Transcription-Polymerase Chain Reaction (RT-PCR).
Total RNA was isolated from macrophages activated with LPS (12.5 ng/ml) and IFNγ (12.5 U/ml) for 8 h by using the RNeasy JPET #63693
8 kit (Qiagen, Hilden, Germany) according to the manufacturer's instruction. Northern blotting was carried out as described , and analyzed with a BAS Image Analyzer (BAS-2500, Fuji film).
For RT-PCR, cDNA was prepared from total RNA (2 µg) using Omniscript RT kit (Qiagen, Hilden, Germany).
PCR amplification was performed in 50 µl solution containing 1.5 mM MgCl 2 , 10 mM Tris-HCl, 50 mM KCl, four dNTPs (0.2 mM each), 2 U Taq DNA polymerase (Clontech, Palo Alto, CA), and either 400 ng iNOS primers or 2 pmol/ml glyceraldehydes-3-phosphage dehydrogenase (G3PDH) Elmer, Norwalk, CT). The predicted sizes of PCR products are 496 bp for iNOS, and 465 bp for G3PDH.
Quantification of PCR products was performed using the BAS Image Gauger Densitometry Software (Fuji Film, Tokyo, Japan).
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Results
Inhibitory Effects of DHCD on NO Production from Macrophages. In order to examine the effect of DHCD on NO production by macrophages, peritoneal macrophages from ICR mice were treated with DHCD (0-80 µM) for 4 h, and then activated with LPS and IFNγ. After 12 h of activation, nitrite concentration in the media was measured as a replication of cumulative NO production. In peritoneal macrophages, NO production gradually decreased with increasing concentrations of DHCD, and was almost completely abolished by 80 µM DHCD (Fig. 2) . ED 50 of the inhibition was ~13 µM.
When the viability of the peritoneal macrophages was measured by MTT assay, it was not decreased by the concentrations of DHCD used (Fig. 2) . Cell viability was also tested by several other methods. Crystal violet staining of viable cells and trypan blue dye-exclusion by living cells were not decreased by 80 µM DHCD (data not shown). These results suggested that used concentrations of DHCD in the present study were non-toxic to peritoneal macrophages. Dimethylsulfoxide in 0.01%, the highest concentration used to dissolve DHCD, was neither toxic to macrophages nor inhibitory to NO production. When the concentration of nitrate, a further oxidation product of NO, was measured together with nitrite, similar inhibitory effect of DHCD on NO generation from peritoneal macrophages was also obtained (data not shown).
The inhibitory effect of DHCD on NO generation was also tested in vivo. LPS (5 mg/kg body weight) was injected into the peritoneal cavity of mice, and the serum concentration of nitrate plus nitrite was measured after 12 h. The concentration was increased to 505.5 ± 103.6 µM (n = 5) from 39.6 ± 5.6 µM (n = 5) by the LPS JPET #63693
1 0 treatment. When DHCD (5 mg/kg body weight) was injected two times, 12 h before and 6 h after the LPS injection, NO production was inhibited by ~70% (178 ± 68.6 µM, n = 5). These results demonstrate that DHCD effectively blocks NO production in macrophage culture and in vivo.
Inhibition of iNOS Expression by DHCD.
In order to examine the effect of DHCD on the iNOS protein expression in macrophages, cells were pretreated with DHCD for 4 hours, activated with LPS and IFNγ for 12 h, and then iNOS expression analyzed in macrophage lysates. The expression level of iNOS protein was markedly reduced by DHCD in a dose-dependent manner (Fig. 3) . When the protein level was estimated by densitometry, 80 µM DHCD inhibited protein expression by ~89%. These results show that DHCD effectively blocked NO production by inhibiting expression iNOS protein in peritoneal macrophages.
Since iNOS protein induction is mainly regulated at the transcription level , the effect of DHCD on iNOS mRNA levels in macrophages was examined. Cells were treated with DHCD and activated with LPS and IFNγ for 8 hours, their total RNA was extracted, and level of iNOS mRNA was estimated by Northern analysis. The NO production at 8 hours was decreased by ~66%, ~76%, ~88% and ~91% at 10, 20, 40
and 80 µM DHCD, respectively (Fig. 4A ). Although the iNOS mRNA level seemed not to be decreased by 10 µM DHCD, it was markedly decreased at higher concentrations of DHCD (Fig. 4B) .
In order to confirm the inhibitory effect of DHCD on iNOS mRNA levels, RT-PCR analyses were performed. Total RNA extracted from activated peritoneal macrophages was reacted with reverse transcriptase to obtain cDNA. mRNA level was estimated by PCR as described in Materials and Methods. When number of the JPET #63693
1 1 cycles of the chain reaction was 25, the amount of PCR product for iNOS gene from activated macrophages was decreased by treatment with 40 or 80 µM DHCD (Fig. 5A ). There was no significant change in the level of G3PDH gene by treatment with DHCD. Furthermore, by changing the number of cycles for chain reactions, a decrease of the amount of PCR product for iNOS from the cells treated with DHCD was the most apparent between 21-27 cycles (Fig. 5B) . These results show that the inhibitory effect of DHCD on the NO production is due to decreased mRNA level and expression of the iNOS protein.
Inhibitory effect of DHCD on the activation of NF-κB. Activation of NF-κB was reported to be an essential step in the transcriptional induction of iNOS Kim et al., 1995) . DHCD has a similar backbone with steroid hormones which have known to inhibit iNOS induction by blocking NF-κB activation (Witkowski and Konopa, 1981; Kleinert et al., 1996) . Therefore, inhibitory effect of DHCD on the activation of NF-κB was examined by EMSA. Mouse peritoneal macrophages were pretreated with DHCD and activated with LPS/IFNγ for 30 minutes. Cells were then harvested and their nuclear fractions were analyzed by gel shift assay. Treatment with LPS/IFNγ markedly increased the level NF-κB in nuclear fractions from macrophages, indicating activation of the transcription factor (Fig. 6) . In macrophages, the subunit composition of NF-κB activated by LPS/IFNγ was reported to be mixed dimers of p50/p50, p50/p65 and p50/c-rel Ding et al., 1995) . The addition of DHCD (40, 80 µM) to macrophages blocked the LPS/IFNγ-induced activation of NF-κB. These results are consistent with the result that DHCD was effective in inhibiting NO production in peritoneal macrophages and suggested that the inhibitory effect of DHCD is by blocking the activation of NF-κB.
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Discussion
In the present study we examined the effect of DHCD on NO production from mouse peritoneal macrophages.
DHCD effectively blocked NO production from peritoneal macrophages with an ED 50 of ~13 µM. DHCD did not show apparent cytotoxic to peritoneal macrophages. Inhibitory effects of DHCD on the expression of iNOS protein and mRNA were demonstrated by Western analysis, Northern blotting, and RT-PCR. Activation of NF-κB, an essential process in iNOS induction, was almost completely blocked. These results suggest that DHCD is effective in primary macrophages for inhibiting NO production, and the effect might occur via inhibiting NF-κB activation.
Cucurbitacins isolated from plants in Cucurbitaceae genus were studied as anticancer agents (Konopa et al., 1974a and 1974b; Cordell and Farnsworth, 1977) . Cucurbitacin was demonstrated to inhibit the biosyntheses of DNA, RNA and proteins in the HeLa S3 cell line (Witkowski et al., 1984) , and to block two-stage carcinogenesis in skin (Konoshima et al., 1994) . Cucurbitacin E was also demonstrated to disrupt the cytoskeleton in prostate carcinoma cells (Duncan et al., 1996) . Recently, it was shown that cucurbitacin I effectively blocked the growth of several tumor cells by disrupting STAT3 signaling pathways (Blaskovich et al., 2003) . In spite of all these results on cancer cells, cucurbitacins have not been developed as anticancer drugs, because many cucurbitacins are toxic not only to cancer cells but also to normal cells (Konopa et al., 1974a and 1974b) . However, the cucurbitacin used in the present study, DHCD, did not show apparent toxicities to normal cells (Sohn et al., 2000 ; this study). Thus, DHCD might be an excellent lead candidate for developing anticancer agents.
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On the other hand, since cucurbitacin B was identified as an effective substance in a fruit juice used as an herbal medicine for allergic rhinitis (Yesilada et al., 1988) , some researchers have studied anti-inflammatory activities of cucurbitacins. Later it was suggested that anti-inflammatory actions of cucurbitacins were attributable to inhibition of prostaglandin E2 biosynthesis (Peters et al., 1999) . The present study revealed that DHCD inhibited NO generation by peritoneal macrophages. Excessive generation of NO by improper regulation of its production could contribute to inflammation (Nathan, 1992) . Thus, the inhibitory effect of DHCD on NO generation could help explain the anti-inflammatory action of cucurbitacins.
DHCD blocked the activation of NF-κB in the mouse peritoneal macrophages. Activation of NF-κB has been demonstrated as a major control process in the induction iNOS. Thus, the present study showed that the inhibition of iNOS induction by DHCD was caused by blocking of NF-κB activation. Furthermore, activation of NF-κB is also known to regulate the expression of various cytokines related to inflammation, such as tumor necrosis factor, interleukin-1 and interleukin-2 ( Lewis and Manning, 1999; McKay and Cidlowski, 1999) . In addition to the in vitro studies we demonstrated the inhibitory effect of DHCD on LPS-induced NO generation in experimental animals. Therefore, the present study strongly suggests that DHCD is a potent inhibitor for the activation of NF-κB and NO production, and thus DHCD could be a useful substance for developing anti- 
